Range Low Price High Price Comment
30 days $20.84 $26.05 Tuesday, 30th Apr 2024 CORT stock ended at $23.32. This is 0.214% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 2.81% from a day low at $23.29 to a day high of $23.94.
90 days $20.84 $26.05
52 weeks $20.84 $34.28

Historical Corcept Therapeutics Incorporated prices

Date Open High Low Close Volume
Jan 13, 2022 $18.85 $18.88 $18.47 $18.55 476 200
Jan 12, 2022 $19.23 $19.42 $18.74 $18.84 480 500
Jan 11, 2022 $19.32 $19.45 $18.91 $19.22 435 700
Jan 10, 2022 $18.78 $19.23 $18.60 $19.19 1 208 300
Jan 07, 2022 $19.28 $19.58 $18.85 $18.95 478 000
Jan 06, 2022 $19.70 $20.04 $19.11 $19.19 698 200
Jan 05, 2022 $20.50 $20.89 $19.71 $19.72 739 694
Jan 04, 2022 $20.38 $20.50 $19.76 $20.46 652 057
Jan 03, 2022 $19.81 $20.37 $19.52 $20.34 2 031 290
Dec 31, 2021 $19.73 $20.38 $19.49 $19.80 998 871
Dec 30, 2021 $19.26 $19.90 $18.81 $19.48 802 584
Dec 29, 2021 $19.11 $19.46 $18.76 $19.26 2 772 954
Dec 28, 2021 $19.61 $19.86 $19.15 $19.18 892 135
Dec 27, 2021 $19.90 $19.90 $19.26 $19.62 1 036 508
Dec 23, 2021 $19.78 $20.12 $19.12 $19.85 1 891 486
Dec 22, 2021 $20.50 $20.50 $19.80 $19.83 2 237 690
Dec 21, 2021 $21.00 $21.00 $20.19 $20.54 2 374 987
Dec 20, 2021 $18.36 $20.84 $18.36 $20.80 1 998 601
Dec 17, 2021 $17.92 $18.92 $17.42 $18.86 4 331 349
Dec 16, 2021 $19.06 $19.20 $17.50 $17.70 8 081 028
Dec 15, 2021 $19.80 $19.86 $18.75 $19.30 8 794 778
Dec 14, 2021 $18.69 $19.52 $18.41 $19.11 6 071 978
Dec 13, 2021 $18.80 $19.43 $18.51 $18.70 2 708 100
Dec 10, 2021 $17.52 $19.14 $17.50 $18.75 3 089 940
Dec 09, 2021 $18.20 $19.00 $17.03 $17.10 4 657 087
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT